JFS Wealth Advisors LLC Sells 538 Shares of CVS Health Corporation $CVS

JFS Wealth Advisors LLC cut its holdings in shares of CVS Health Corporation (NYSE:CVSFree Report) by 9.7% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,984 shares of the pharmacy operator’s stock after selling 538 shares during the period. JFS Wealth Advisors LLC’s holdings in CVS Health were worth $344,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Jennison Associates LLC lifted its holdings in CVS Health by 503.8% during the 1st quarter. Jennison Associates LLC now owns 1,896,341 shares of the pharmacy operator’s stock worth $128,477,000 after buying an additional 1,582,257 shares in the last quarter. Cantor Fitzgerald Investment Advisors L.P. lifted its holdings in CVS Health by 1.6% during the 2nd quarter. Cantor Fitzgerald Investment Advisors L.P. now owns 409,735 shares of the pharmacy operator’s stock worth $28,264,000 after buying an additional 6,615 shares in the last quarter. Cerity Partners LLC lifted its holdings in CVS Health by 25.0% during the 1st quarter. Cerity Partners LLC now owns 648,266 shares of the pharmacy operator’s stock worth $43,920,000 after buying an additional 129,535 shares in the last quarter. Bank of New York Mellon Corp lifted its holdings in CVS Health by 2.1% during the 1st quarter. Bank of New York Mellon Corp now owns 8,981,262 shares of the pharmacy operator’s stock worth $608,481,000 after buying an additional 183,813 shares in the last quarter. Finally, Brandywine Global Investment Management LLC lifted its holdings in CVS Health by 20.1% during the 1st quarter. Brandywine Global Investment Management LLC now owns 3,421,519 shares of the pharmacy operator’s stock worth $231,808,000 after buying an additional 572,533 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analyst Ratings Changes

A number of research firms have recently weighed in on CVS. Cowen reissued a “buy” rating on shares of CVS Health in a research note on Monday, August 4th. Morgan Stanley increased their price target on CVS Health from $80.00 to $82.00 and gave the company an “overweight” rating in a research note on Friday, August 1st. Wall Street Zen raised CVS Health from a “hold” rating to a “buy” rating in a research note on Sunday, September 21st. UBS Group raised CVS Health from a “neutral” rating to a “buy” rating and increased their price target for the company from $67.00 to $79.00 in a research note on Monday, August 18th. Finally, Barclays increased their price target on CVS Health from $80.00 to $87.00 and gave the company an “overweight” rating in a research note on Thursday, September 4th. Two analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $79.80.

Read Our Latest Stock Analysis on CVS Health

CVS Health Stock Performance

Shares of CVS Health stock opened at $77.89 on Friday. The company has a market capitalization of $98.79 billion, a PE ratio of 21.76, a PEG ratio of 0.86 and a beta of 0.60. CVS Health Corporation has a 12 month low of $43.56 and a 12 month high of $79.20. The company has a current ratio of 0.80, a quick ratio of 0.62 and a debt-to-equity ratio of 0.74. The stock’s fifty day simple moving average is $72.28 and its 200 day simple moving average is $67.67.

CVS Health (NYSE:CVSGet Free Report) last issued its quarterly earnings data on Thursday, July 31st. The pharmacy operator reported $1.81 EPS for the quarter, topping the consensus estimate of $1.46 by $0.35. The business had revenue of $98.92 billion for the quarter, compared to the consensus estimate of $94.87 billion. CVS Health had a return on equity of 10.51% and a net margin of 1.17%.The firm’s revenue was up 8.4% compared to the same quarter last year. During the same quarter last year, the business posted $1.83 EPS. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. On average, research analysts predict that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, November 3rd. Shareholders of record on Thursday, October 23rd will be issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 3.4%. The ex-dividend date is Thursday, October 23rd. CVS Health’s dividend payout ratio is 74.30%.

Insider Transactions at CVS Health

In other CVS Health news, Director Anne A. Finucane sold 7,500 shares of the stock in a transaction dated Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total transaction of $532,650.00. Following the completion of the transaction, the director owned 22,156 shares in the company, valued at approximately $1,573,519.12. This represents a 25.29% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.22% of the company’s stock.

About CVS Health

(Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Further Reading

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.